Related Experiment Video
Updated: Jan 8, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Laboratory Testing of Direct Oral Anticoagulants
1UK NEQAS (Blood Coagulation), Sheffield, UK. christopher.reilly-stitt@nhs.net.
None:
Direct oral anticoagulants (DOACs), also referred to as non-vitamin K oral anticoagulants (NOACs), have revolutionised anticoagulant therapy since their introduction in the late 2000s. These agents - dabigatran (a direct thrombin inhibitor) and the factor Xa inhibitors apixaban, edoxaban, and rivaroxaban - offer more predictable pharmacokinetics, fewer food and drug interactions, and do not typically require routine laboratory monitoring, unlike traditional anticoagulants such as warfarin and heparin. Despite these advantages, laboratory assessment of DOAC activity remains clinically important in specific circumstances, including bleeding, thrombosis during therapy, emergency surgery, renal or hepatic impairment, and suspected non-compliance.This chapter reviews the pharmacology, clinical applications, and laboratory evaluation of DOACs, outlining available assays and their principles. The gold standard for quantification is liquid chromatography-tandem mass spectrometry (LC-MS/MS), though chromogenic anti-Xa and dilute thrombin time (DTT) or ecarin-based assays are more commonly used in clinical laboratories. The impact of DOACs on routine coagulation tests such as PT, APTT, and TT is variable and reagent dependent, underscoring the need for drug-specific calibrators and assay validation.Quality assurance through both internal quality control (IQC) and external quality assessment (EQA) is essential to maintain assay accuracy and reproducibility, in accordance with ISO 15189:2022 standards. Furthermore, DOACs can interfere with other haemostasis assays - including factor assays, antithrombin, and lupus anticoagulant testing - leading to potential diagnostic errors. Recent studies demonstrate that activated charcoal-based reagents, such as DOAC Remove™ and DOAC Stop™, can effectively neutralise DOAC interference in such assays.In conclusion, while DOACs have largely supplanted warfarin in the management of non-valvular atrial fibrillation and venous thromboembolism due to their safety and convenience, laboratory testing retains a critical role in ensuring safe and effective patient management under specific clinical scenarios.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Therapeutic Drug Monitoring: Drug Analysis Methods
EDTA: Direct, Back-, and Displacement Titration
Direct titration involves buffering the metal ion solution to the desired pH and directly titrating with standard EDTA until the endpoint. The optimum pH ensures a large conditional formation constant of metal−EDTA and visibility of the free indicator color in the solution. In addition, auxiliary complexing reagents are used to prevent the precipitation of metal hydroxides...
EDTA: Indirect and Alkalimetric Titration

